Clinical Trial

Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection

Name: Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection — clinical trial record (NCT07028970)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This is a multicenter, open-label, single-arm, long-term follow-up clinical study. All patients who have received Equecabtagene Autoleucel Injection treatment will be enrolled.

Trial Details

NCT Number	NCT07028970
Lead Sponsor	Nanjing IASO Biotechnology Co., Ltd.
Conditions	Multiple Myeloma
Enrollment	1,500 participants
Start Date	2024-12-15
Primary Completion	2040-12 (estimated)
Study Completion	2043-12 (estimated)
Updated on ClinicalTrials.gov	2025-06-19